Nephros Inc expected to post breakeven results a share - Earnings Preview
Nephros Inc <NEPH.OQ> expected to post breakeven results a share - Earnings Preview
Nephros Inc NEPH.OQ NEPH.O is expected to show a rise in quarterly revenue when it reports results on August 5 (estimated) for the period ending June 30 2026
The South Orange New Jersey-based company is expected to report a 13.0% increase in revenue to $4.994 million from $4.42 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Nephros Inc is for breakeven results per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Nephros Inc is $6.00, about 77% above its last closing price of $3.39
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | 0.01 | 0.01 | 0.01 | Met | 0 |
Dec. 31 2026 | 0.01 | 0.08 | Beat | 700 | |
Sep. 30 2025 | -0.02 | -0.02 | 0.03 | Beat | 250 |
Jun. 30 2025 | -0.02 | -0.02 | 0.02 | Beat | 180 |
Mar. 31 2025 | 0.00 | 0.00 | 0.05 | Beat | 1,100 |
Dec. 31 2024 | -0.01 | 0.03 | Beat | 300 | |
Sep. 30 2024 | -0.02 | -0.02 | 0.02 | Beat | 200 |
Jun. 30 2024 | -0.01 | -0.03 | Missed | -100 |
This summary was machine generated August 3 at 11:23 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)